Troy– Author –
-
AstraZeneca Accelerates Next-Gen Cell Therapy Manufacturing: Gracell’s Rapid Platform Reduces Autologous CAR T Production Time
AstraZeneca UK Overview AstraZeneca is addressing critical challenges in cell therapy by accelerating autologous cell therapy manufacturing and advancing allogeneic and in vivo 'off-the-shelf' approaches. Notably, they are leveraging Gra... -
Liv Hospital Details Advanced ‘Off-the-Shelf’ CAR-T Manufacturing, Promising Scalability and Broader Access
Liv Hospital Turkey Overview Liv Hospital has unveiled its detailed manufacturing process for allogeneic, 'off-the-shelf' CAR-T cell therapy, a significant leap towards overcoming the logistical and cost barriers of current personalized ... -
Closed, Automated Culture Systems Critical for iPSC Therapy Manufacturing to Ensure GMP and Scalability
Contract Pharma USA Overview iPSC-derived cell therapies are rapidly emerging as scalable solutions across regenerative medicine and oncology, yet ensuring GMP-grade production and consistency across large-scale manufacturing platforms r... -
NueCell Bio Unveils 26,300 Sq Ft Cell Therapy Development Facility in San Diego, Bolstering Clinical & Commercial Manufacturing
PharmaSource USA Overview NueCell Bio has officially opened its 26,300-square-foot cell therapy development facility in San Diego, significantly enhancing its clinical and commercial manufacturing capabilities. The state-of-the-art facil... -
Biopharmaceutical CDMO Capacity Crunch Persists, Driving Rapid Expansion in Cell and Gene Therapy Production
Contract Pharma USA Overview The biopharmaceutical industry continues to face a CDMO capacity crunch, prompting contract development and manufacturing organizations to heavily invest in expanding production capabilities, particularly for... -
Digital Twin Technology Accelerates Bioprocess Optimization, Enabling Real-time Monitoring and Cost Reduction
Jojo Imats (Facebook) Global Overview Digital twin technology is transforming traditional manufacturing workflows into data-driven ecosystems, monitoring every stage from design to operation in real-time. Bioprocess engineers can optimiz... -
Japan’s Regenerative Medicine Regulated by Two Pillars: Approved Cell Products and Registered Private Treatments, Emphasizing Safety and Quality
Stem Cell Clarity Japan Overview Japanese regenerative medicine is governed by two distinct legal frameworks: cell products approved by the Minister of Health, Labour and Welfare, and private treatments under a registration system where ... -
Oxford Biomedica Launches Fast-Track Viral Vector Service, Accelerating Gene Therapy Development by Cutting Manufacturing Times by up to 8 Months
Kalkine UK Overview Oxford Biomedica has launched a fast-track viral vector service to accelerate gene therapy development. This new service shortens GMP-grade manufacturing for AAV vectors from approximately 15 months to as little as 7 ... -
Azunic AI Adopts Inventia Life Science’s RASTRUM 3D Cell Culture Platform to Accelerate Human-Relevant In Vitro Toxicology
BusinessWire USA Overview Azunic AI has adopted Inventia Life Science's RASTRUM 3D cell culture platform to accelerate the development of an animal-free, human-relevant 3D in vitro toxicology platform. RASTRUM's precision bioprinting, de... -
Texas Children’s Hospital’s GMP Facility Manufactures Over 10,000 Cell Therapy Products in 20 Years, Driving CGT Innovation
Texas Children's Hospital USA Overview Texas Children's Hospital's Center for Cell and Gene Therapy (CAGT) has manufactured over 10,000 cell therapy products and more than 70 clinical-grade viral vectors over two decades, utilizing its i...
